| Value | ₹23.68 Cr |
|---|
NSE filing, NSE: PASHUPATI. Summary written from the filing by ALFA Finder's alert engine.
Pashupati Cotspin Ltd: key numbers
- Share price
- ₹121.53
- Market cap
- ₹1,918 Cr
- Revenue (annual)
- ₹687.8 Cr
- Net profit (annual)
- ₹10.39 Cr
- P/E (TTM)
- 122.5×Sector 49.5×
- Promoter holding
- 65.99%+0.00% QoQ
- FII holding
- 12.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pashupati Cotspin Ltd
All →Pashupati Cotspin Price Movement Clarification
Pashupati Cotspin clarified that recent stock price movements were purely market-driven, confirming no undisclosed material information exists.
Pashupati Cotspin Other Announcement
Pashupati Cotspin Limited submitted the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as per SEBI regulations.
Pashupati Cotspin Other Announcement
Pashupati Cotspin Limited submitted the required Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Pashupati Cotspin Bonus Issue
Pashupati Cotspin Limited issued a Postal Ballot notice to shareholders seeking approval for an increase in authorised share capital and the issuance of bonus shares.
Pashupati Cotspin Bonus Issue
Pashupati Cotspin Limited recommended a 3:2 bonus share issue in its board meeting. The company will capitalize reserves for this issuance.
Pashupati Cotspin Annual General Meeting
Pashupati Cotspin Limited held its 9th Annual General Meeting on September 30, 2026, transacting various ordinary and special business items.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.